Alginate-based materials have received considerable attention for biomedical applications because of their hydrophilic nature, biocompatibility, and physical architecture. Applications include cell encapsulation, drug delivery, stem cell culture, and tissue engineering scaffolds. In fact, clinical trials are currently being performed in which islets are encapsulated in PLO coated alginate microbeads as a treatment of type I diabetes. However, large numbers of islets are required for efficacy due to poor survival following transplantation. The ability to locally stimulate microvascular network formation around the encapsulated cells may increase their viability through improved transport of oxygen, glucose and other vital nutrients. Fibroblast growth factor-1 (FGF-1) is a naturally occurring growth factor that is able to stimulate blood vessel formation and improve oxygen levels in ischemic tissues. The efficacy of FGF-1 is enhanced when it is delivered in a sustained fashion rather than a single large-bolus administration. The local long-term release of growth factors from islet encapsulation systems could stimulate the growth of blood vessels directly towards the transplanted cells, potentially improving functional graft outcomes. In this article, we outline procedures for the preparation of alginate microspheres for use in biomedical applications. In addition, we describe a method we developed for generating multilayered alginate microbeads. Cells can be encapsulated in the inner alginate core, and angiogenic proteins in the outer alginate layer. The release of proteins from this outer layer would stimulate the formation of local microvascular networks directly towards the transplanted islets.
[1]
B. Amsden,et al.
Diffusion characteristics of calcium alginate gels.
,
1999,
Biotechnology and bioengineering.
[2]
E. Opara,et al.
Characteristics of Poly-L-Ornithine-coated alginate microcapsules.
,
2005,
Biomaterials.
[3]
O. Khanna,et al.
Multilayered microcapsules for the sustained-release of angiogenic proteins from encapsulated cells.
,
2010,
American journal of surgery.
[4]
E. Brey,et al.
Sustained delivery of FGF-1 increases vascular density in comparison to bolus administration.
,
2009,
Microvascular research.
[5]
E. Brey,et al.
The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering.
,
2010,
Biomaterials.
[6]
Monica L Moya,et al.
Synthesis of multilayered alginate microcapsules for the sustained release of fibroblast growth factor-1.
,
2010,
Journal of biomedical materials research. Part A.
[7]
E. Brey,et al.
Sustained low levels of fibroblast growth factor-1 promote persistent microvascular network formation.
,
2006,
American journal of surgery.
[8]
K. Yamagiwa,et al.
Effects of Alginate Composition and Gelling Conditions on Diffusional and Mechanical Properties of Calcium-Alginate Gel Beads
,
1995
.